T. Hodge

Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome

R. Carback, T. Brasel, C. Herst, 2020, bioRxiv.

A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques

R. Carback, S. Ciotlos, T. Brasel, 2021, bioRxiv.

An effective CTL peptide vaccine for Ebola Zaire Based on Survivors’ CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design

J Sidney, J. Sidney, A. Sette, 2020, bioRxiv.

Paired SARS-CoV-2 spike protein mutations observed during ongoing SARS-CoV-2 viral transfer from humans to minks and back to humans

S. Pokhrel, R. Carback, S. Ciotlos, 2020, bioRxiv.

anti-IL-6 versus anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice with Potential Implications for Treating Patients Presenting with COVID-19

R. Carback, T. Brasel, C. Herst, 2020 .